Note: Ingredients listed on restricted chemical lists
EC/CAS
231-096-4/7440-47-3
Name of the chemical
Chromium; chromic acid and its salts
Concentration
15.5 - 16.1
EC/CAS
231-157-5/7440-02-0
Name of the chemical
Nickel
Concentration
3.9 - 4.4
EC/CAS
231-159-6/7440-50-8
Name of the chemical
Copper
Concentration
3.7 - 4.2
EC/CAS
215-168-2
Name of the chemical
Iron Oxide Red
Concentration
74.3-76
EC/CAS
231-111-4
Name of the chemical
Nickel, Metall (790/2009)
Concentration
N/A
General Information
Version
3.1
Revision date
2023-11-03
Product name
EOS StainlessSteel 17-4PH
supplier name
Electro Optical Systems Finland Oy
Emergency telephone
+49 (0) 89 / 893 36 - 0, +49 (0) 89 / 893 36 - 151
Icons in SDS
Company Information
company name
Electro Optical Systems Finland Oy
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSInfo@eos.info
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H351, H373, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available EN (English) 1/11
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
Nickel
Hazard statements
H317 - May cause an allergic skin reaction. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P201 - Obtain special instructions before use. P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P321 - Specific treatment (see supplemental first aid instruction on this label).
2.3 Other hazards
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
